- Home
- HBCP vs MRVI Comparison
HBCP vs MRVI Comparison
Compare HBCP & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBCP
- MRVI
- Stock Information
- Founded
- HBCP 1908
- MRVI 2014
- Country
- HBCP United States
- MRVI United States
- Employees
- HBCP N/A
- MRVI N/A
- Industry
- HBCP Banks
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- HBCP Finance
- MRVI Health Care
- Exchange
- HBCP Nasdaq
- MRVI Nasdaq
- Market Cap
- HBCP 342.0M
- MRVI 312.4M
- IPO Year
- HBCP 2008
- MRVI 2020
- Fundamental
- Price
- HBCP $50.78
- MRVI $2.24
- Analyst Decision
- HBCP Buy
- MRVI Hold
- Analyst Count
- HBCP 2
- MRVI 10
- Target Price
- HBCP $57.50
- MRVI $6.84
- AVG Volume (30 Days)
- HBCP 61.0K
- MRVI 1.5M
- Earning Date
- HBCP 07-16-2025
- MRVI 08-06-2025
- Dividend Yield
- HBCP 2.12%
- MRVI N/A
- EPS Growth
- HBCP 0.90
- MRVI N/A
- EPS
- HBCP 4.78
- MRVI N/A
- Revenue
- HBCP $135,421,000.00
- MRVI $241,856,000.00
- Revenue This Year
- HBCP $0.25
- MRVI N/A
- Revenue Next Year
- HBCP $5.18
- MRVI $10.73
- P/E Ratio
- HBCP $10.66
- MRVI N/A
- Revenue Growth
- HBCP 3.44
- MRVI N/A
- 52 Week Low
- HBCP $37.35
- MRVI $1.67
- 52 Week High
- HBCP $52.77
- MRVI $10.03
- Technical
- Relative Strength Index (RSI)
- HBCP 58.65
- MRVI 52.32
- Support Level
- HBCP $48.30
- MRVI $2.00
- Resistance Level
- HBCP $51.95
- MRVI $2.24
- Average True Range (ATR)
- HBCP 1.08
- MRVI 0.14
- MACD
- HBCP 0.03
- MRVI -0.00
- Stochastic Oscillator
- HBCP 77.53
- MRVI 50.00
About HBCP Home Bancorp Inc.
Home Bancorp Inc is engaged in attracting deposits from the public and using those funds to invest in loans and securities. The principal sources of funds are customer deposits, repayments of loans, repayments of investments and funds borrowed from outside sources such as the Federal Home Loan Bank of Dallas. These funds are used for the origination of loans, including one-to-four-family first mortgage loans, home equity loans, and lines, commercial real estate loans, construction and land loans, multi-family residential loans, commercial and industrial loans, and consumer loans.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.